Identité

Spinosad Impurity PSD

Non indiqué · C34H52O9

01Identité

Lazychem IDLC-37696
CAS RNNon indiqué
PubChem CID73792379
Molecular formulaC34H52O9
Molecular weight604.8 g/mol
IUPAC name19-ethyl-15-hydroxy-4,14-dimethyl-7-(3,4,5-trimethoxy-6-methyloxan-2-yl)oxy-20-oxatetracyclo[10.10.0.02,10.05,9]docosa-3,11-diene-13,21-dione
InChIKeyPGGPPEHRBUYMQU-UHFFFAOYSA-N

02Structure et stéréochimie

2D structurePubChem CID 73792379
Two-dimensional chemical structure of Spinosad Impurity PSD
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 5 rings, includes aliphatic carbon. These statements are calculated from the published structure string.

Defined stereocentres0
Ring count5
Secondary amines0
Tertiary amines0
SMILESCCC1CCCC(C(C(=O)C2=CC3C4CC(CC4C(=CC3C2CC(=O)O1)C)OC5C(C(C(C(O5)C)OC)OC)OC)C)O
InChINon indiqué

03Stereochemistry

The published structure contains 0 defined and 14 unassigned tetrahedral stereocentres. The exact wedge and dash depiction is shown above.

Defined centres0Structure assigned
Unassigned centres14Structure unspecified
Assignment statusUnassignedExact published identity
Tetrahedral upper bound≤ 16,384Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04Statut en Inde

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05Noms et relations

API et médicament parent

Non indiqué

Noms et relations

    Impuretés et composés apparentés

      06Sources